Clinical Trials Sponsored by Institut de l'Atherothrombose

Total 5543 results

Institut de l'Atherothrombose

Completed

EValuation of Systemic Atherothrombosis in Patients With ARTerial Disease of the Lower Limbs (EVART)

Peripheral Arterial Disease | Carotid Stenosis | Abdominal Aortic Aneurysm

France, Belgium
Assistance Publique - Hôpitaux de Paris
Institut de l'Atherothrombose

Completed

Active Detection of the Extension of Atherothrombosis in High Risk Coronary Patients (AMERICA)

Coronary Artery Disease

France
Institut de Recerca Biomèdica de Lleida
Instituto de Salud Carlos III

Recruiting

Longitudinal Recovery Trajectories After an Acute Respiratory Distress Syndrome, a New Understanding (TENACITY)

ARDS | ARDS Disease Progression

Spain
Institut de Recerca Biomèdica de Lleida
Instituto de Salud Carlos III

Recruiting

Compromised Sleep and Circadian Health After Critical Illness: From Diagnosis to Prediction (CHRONOCRIT) (CHRONOCRIT)

Sleep Fragmentation | Circadian Dysregulation

Spain
Institut de Recerca Biomèdica de Lleida
Instituto de Salud Carlos III

Active, not recruiting

REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients ( REMOTE-CAT) (REMOTE-CAT)

Ischemic Stroke

Spain
Montreal Heart Institute
Institut de Recherches Cliniques de Montreal

Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II (APPEASEDII)

Diabetes Mellitus, Type 2 | Type 2 Diabetes | Platelet Aggregation | Aspirin | Platelet Aggregation Inhibitors

Canada
Montreal Heart Institute
Institut de Recherches Cliniques de Montreal

Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes (APPEASED)

Diabetes Mellitus, Type 2

Canada
Instituto de Salud Carlos III
Institut de Recerca Biomèdica de Lleida; Instituto Murciano de Investigación...

Completed

Circadian Health and Influential Factors (CHRONOHOSPI)

Chronobiology Disorders

Spain
Institut de Cancérologie de la Loire
National Cancer Institute, France

Unknown

I2S-Health Prevention (I2S)

Secondary School Student in General High School Who Does Not Have a Disability That Does Not Allow a Good Understanding of the Study Requirements

United States, France
Institut de Recherches Cliniques de Montreal
Ottawa Hospital Research Institute

Completed

Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

Hypertension

Canada
Institut de Cancérologie de Lorraine

Recruiting

Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination (HISTOBLOC)

Squamous Cell Carcinoma of Head and Neck | Basal Cell Carcinoma of Skin

France
Institut de Cancérologie de Lorraine

Recruiting

Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) (HYMACO)

Head and Neck Tumors

France
Institut de Cancérologie de Lorraine

Active, not recruiting

Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal (BOVARY CE)

Ovarian Cancer

France
Institut de Cancérologie de Lorraine

Completed

Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)

Breast Cancer | Prostate Cancer

France
Institut de Cancérologie de Lorraine

Completed

CIrCuLAting Dna ESr1 Gene Mutations Analysis (CICLADES)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma (OPTIMEL)

Melanoma (Skin)

France
Institut de Cancérologie de Lorraine

Completed

Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients (HYCUDES)

Cancer | Brachytherapy

France
Institut de Cancérologie de Lorraine

Terminated

Description of Individual Radiosensitivity With Molecular Biomarkers in a Pediatric Oncology Population (ARPEGE BioM)

Cancer-related Problem/Condition

France
Institut de Cancérologie de Lorraine

Completed

Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer (TRIDICOL)

Cervical Adenocarcinoma | Stage IB Cervical Cancer | Stage III Cervical Cancer | Stage II Cervical Cancer

France
Institut de Cancérologie de Lorraine

Completed

Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor. (EFESE)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Metastatic Breast Carcinoma and Women Sexual Quality of Life (SexoMBC)

Metastatic Breast Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer (VESICOL)

Cervical Cancer

France
Institut de Cancérologie de Lorraine

Completed

Validation of a Medical Device, a Mobile Spectrofluorimeter, Measuring Skin Autofluorescence in Healthy Volunteers. (PHOTOFLUO)

Healthy Volunteers

France
Institut de Cancérologie de Lorraine

Completed

Feasibility Study of Breast MRI in Decubitus Position (EFIMED)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Use of Compressed Sensing in Breast MRI (COMPRIM)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

HCC Response Assessment by MRI After SBRT

Carcinoma, Hepatocellular
Institut de Cancérologie de Lorraine

Recruiting

Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted. (PROTOTOX)

Quality of Life | Cancer | Hearing Disorders | Ototoxicity, Drug-Induced

France
Institut de Cancérologie de Lorraine

Not yet recruiting

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) (EFACog)

No Metastatic Breast Cancer

France
Institut de Cancérologie de Lorraine

Recruiting

Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia (PhotodiVIN)

Vulvar Intraepithelial Neoplasia | Vulvar High Grade Squamous Intraepithelial Lesion | Differentiated Vulvar Intraepithelial Neoplasia

France
Institut de Cancérologie de Lorraine

Recruiting

Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) (PERCIMEL)

Melanoma

France
Institut de Cancérologie de Lorraine

Recruiting

Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC (PIPADN)

Peritoneal Carcinomatosis

France
Institut de Cancérologie de Lorraine

Completed

Unusual Toxicity Induced by Radiotherapy (CRYOTOX)

Cancer

France
Institut de Cancérologie de Lorraine

Completed

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure (ANIBPV)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch (ENHYZA)

Pain

France
Institut de Cancérologie de Lorraine

Completed

Mastectomy in Ambulatory Breast Surgery (MASTAMBU)

Mastectomy

France
Institut de Cancérologie de Lorraine

Completed

Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area (SALVADS-Fluo)

Head and Neck Cancer

France
Institut de Cancérologie de Lorraine

Completed

Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection (CyPaM2)

Bladder Cancer

France
Institut de Cancérologie de Lorraine

Completed

Place of General Medical During Oncology Care Management (MGPEC_Onco)

Oncologic Disorders

France
Institut de Cancérologie de Lorraine

Completed

RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer (SPLICI-Rad)

Fibrosis | Breast Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma (HACAMI)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Feasibility Study of Supine Breast MRI : Comparison With Prone MRI and Comfort Assessment

Breast Diseases
Institut de Cancérologie de Lorraine

Completed

A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas

Sarcoma,Soft Tissue
Institut de Cancérologie de Lorraine

Completed

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

Brain Metastasis

France
Institut de Cancérologie de Lorraine

Recruiting

Psycho-social Determinant for Sport Practised During Cancer (PERTINENCE)

Cancer | Physical Activity

France
Institut de Cancérologie de Lorraine

Completed

Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients (IASAAC)

Solid Tumor

France
Institut de Cancérologie de Lorraine

Active, not recruiting

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Pancreatic Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

SexoMBC2 Non Interventional Study (SexoMBC2)

Quality of Life | Breast Cancer | Sexual Behavior

France
Institut de Cancérologie de Lorraine

Completed

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (GASVERT)

Head and Neck Cancer | Breast Carcinoma | Cervix Cancer | Melanoma (Skin) | Ovary Cancer | Rectum Cancer | Endometrium Cancer | Vulva Cancer | Squamous Cell Carcinoma, Skin | Anus Cancer

France
Institut de Cancérologie de Lorraine

Terminated

Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer (HYCOREMA)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort (PAPILLOR)

Human Papillomavirus-Related Cervical Carcinoma

France

Clinical Trials Sponsored by Institut de l'Atherothrombose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations